Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study

被引：0
|
作者：
Kwadwo Antwi
Melpomeni Fani
Tobias Heye
Guillaume Nicolas
Christof Rottenburger
Felix Kaul
Elmar Merkle
Christoph J. Zech
Daniel Boll
Deborah R. Vogt
Beat Gloor
Emanuel Christ
Damian Wild
机构：
[1] University Hospital Basel,Clinic of Radiology and Nuclear Medicine
[2] University Hospital Basel,Centre for Neuroendocrine and Endocrine Tumours
[3] University Hospital Basel and University of Basel,Clinical Trial Unit, Department of Clinical Research
[4] University Hospital of Bern,Department of Visceral Surgery
[5] University Hospital Basel,Division of Endocrinology, Diabetology and Metabolism
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词：
Insulinoma; Glucagon-like peptide-1 receptor; GLP-1R PET/CT; GLP-1R SPECT/CT; MRI; Ga-DOTA-exendin-4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2318 / 2327
页数：9
相关论文
共 6 条
  • [1] Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study
    Antwi, Kwadwo
    Fani, Melpomeni
    Heye, Tobias
    Nicolas, Guillaume
    Rottenburger, Christof
    Kaul, Felix
    Merkle, Elmar
    Zech, Christoph J.
    Boll, Daniel
    Vogt, Deborah R.
    Gloor, Beat
    Christ, Emanuel
    Wild, Damian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (13) : 2318 - 2327
  • [2] Comparison of Glucagon-Like-Peptide-1 (GLP-1) Receptor PET/CT, SPECT/CT and 3T MRI for the Localisation of Insulinomas: Evaluation of Accuracy in a Prospective Crossover Imaging Study
    Antwi, A.
    Heye, T.
    Fani, M.
    Nicolas, G.
    Merkle, E.
    Zech, C.
    Boll, D.
    Rottenburger, C.
    Kaul, F.
    Gloor, B.
    Christ, E.
    Wild, D.
    NEUROENDOCRINOLOGY, 2018, 106 : 167 - 167
  • [3] Sensitivity of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI for the Localization of Benign Insulinomas: Interim Analysis of a Prospective Imaging Efficacy Study
    Antwi, A.
    Fani, M.
    Heye, T.
    Nicolas, G.
    Merkle, E.
    Reubi, J. C.
    Gloor, B.
    Christ, E.
    Wild, D.
    NEUROENDOCRINOLOGY, 2017, 105 : 163 - 163
  • [4] Localisation of Insulinoma and Beta-Cells: Comparison of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI. Preliminary Results of a Prospective Clinical Study
    Rottenburger, C.
    Antwi, K.
    Heye, T.
    Fani, M.
    Nicolas, G.
    Merkle, E.
    Reubi, J. C.
    Gloor, B.
    Christ, E.
    Wild, D.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 115 - 116
  • [5] Glucagon-Like Peptide 1 Receptor (GLP-1R) Imaging for the Preoperative Localization of Benign Insulinomas in 30 Patients
    Christ, E.
    Forrer, F.
    Wild, D.
    Clerici, T.
    Braendle, M.
    Maecke, H.
    Ell, P. J.
    Caplin, M.
    Reubi, J. C.
    NEUROENDOCRINOLOGY, 2012, 96 : 24 - 24
  • [6] Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
    Luo, Yaping
    Pan, Qingqing
    Yao, Shaobo
    Yu, Miao
    Wu, Wenming
    Xue, Huadan
    Kiesewetter, Dale O.
    Zhu, Zhaohui
    Li, Fang
    Zhao, Yupei
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 715 - 720
1